Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters
Science Advances · 02.08.2024 · 10 (31)
DOI: 10.1126/sciadv.adp1290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 02.08.2024. Verfasst von Tamarand L Darling und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, COVID-19 Vaccines, Mesocricetus. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
COVID-19 vaccines have successfully reduced severe disease and death after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nonetheless, COVID-19 vaccines are variably effective in preventing transmission and symptomatic SARS-CoV-2 infection. Here, we evaluated the impact of mucosal or intramuscular vaccine immunization on airborne infection and transmission of SARS-CoV-2 in Syrian hamsters. Immunization of the primary contact hamsters with a mucosal chimpanzee adenoviral-vectored vaccine (ChAd-CoV-2-S), but not intramuscular messenger RNA (mRNA) vaccine, reduced infectious virus titers ~100-fold and 100,000-fold in the upper and lower respiratory tract of the primary contact hamster following SARS-CoV-2 exposure. This reduction in virus titer in the mucosal immunized contact animals was sufficient to eliminate subsequent transmission to vaccinated and unvaccinated hamsters. In contrast, sequential transmission occurred after systemic immunization with the mRNA vaccine. Thus, immunization with a mucosal COVID-19 vaccine protects against cycles of respiratory transmission of SARS-CoV-2 and can potentially limit the community spread of the virus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
ORCID-Profile: Tamarand L Darling, Houda H Harastani, Astha Joshi, Nadia Soudani, Kuljeet Seehra, Michael S Diamond, Adrianus C M Boon
Förderung
- NIAID NIH HHS
Zitieren
APA
Darling, T. L., Harastani, H. H., Joshi, A., Bricker, T. L., Soudani, N., Seehra, K., Hassan, A. O., Diamond, M. S., & Boon, A. C. M. (2024). Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters. Science Advances, 10(31). https://doi.org/10.1126/sciadv.adp1290
Vancouver
Darling TL, Harastani HH, Joshi A, Bricker TL, Soudani N, Seehra K, et al. Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters. Science Advances. 2024;10(31). doi:10.1126/sciadv.adp1290
BibTeX
@article{Darling2024,
author = {Darling, Tamarand L and Harastani, Houda H and Joshi, Astha and Bricker, Traci L and Soudani, Nadia and Seehra, Kuljeet and Hassan, Ahmed O and Diamond, Michael S and Boon, Adrianus C M},
title = {Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {31},
doi = {10.1126/sciadv.adp1290}
}
EUVIMED